SARS-CoV-2 Omicron XBB infections boost cross-variant neutralizing antibodies, potentially explaining the observed delay of the JN.1 wave in some Brazilian regions

The XBB wave observed in the second half of 2023 in some Brazilian states likely acted as a booster for population immunity, providing short-term protection against JN.1 infections and delaying the rise of SARI cases in certain regions of the country.

Authors

Institutions

Publication Details

Journal
IJID Regions
Published
2024-12-04
DOI
https://doi.org/10.1016/j.ijregi.2024.100503
Citations
3
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
1.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SARS-CoV-2 Omicron XBB infections boost cross-variant neutralizing antibodies, potentially explaining the observed delay of the JN.1 wave in some Brazilian regions

Marcelo Ferreira da Costa Gomes, Fábio Miyajima, Patrícia Brasil, Luciana Appolinario et al.
3 citations
IJID Regions
SARS-CoV-2 and COVID-19 Research
1.17
article

SARS-CoV-2 Omicron XBB infections boost cross-variant neutralizing antibodies, potentially explaining the observed delay of the JN.1 wave in some Brazilian regions

Marcelo Ferreira da Costa Gomes, Fábio Miyajima, Patrícia Brasil, Luciana Appolinario, Gabriel Luz Wallau, Jéssica Santa Cruz Carvalho Martins, Marilda Mendonça Siqueira, Elisa Cavalcante Pereira, Felipe Gomes Naveca, Luis Fernando López Tort, Ighor Arantes, Mia Ferreira de Araújo, Paola Cristina Resende, Felipe Cotrim de Carvalho, Otávio de Melo Espíndola, Walquíria Aparecida Ferreira de Almeida, Jéssica Carvalho da Silva, Pedro Augusto Alves, Bráulia Costa Caetano, Gonzalo Bello
article en
3 citations

Abstract

The XBB wave observed in the second half of 2023 in some Brazilian states likely acted as a booster for population immunity, providing short-term protection against JN.1 infections and delaying the rise of SARI cases in certain regions of the country.

IJID RegionsVol. 14
Universidad de la República de Uruguay (UY), Instituto Nacional de Pesquisas da Amazônia (BR), Ministério da Saúde (BR), Instituto Evandro Chagas (BR), Institute of Virology of the Slovak Academy of Sciences (SK), Fundação Oswaldo Cruz (BR), Bernhard Nocht Institute for Tropical Medicine (DE)
Ministério da Ciência, Tecnologia e Inovação, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Fundação Oswaldo Cruz
Good health and well-being
Openalex Percentile: Top 20%
SARS-CoV-2 and COVID-19 Research
1.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.